Experimental models of vascular dementia and vascular cognitive impairment: a systematic review

Nadim S Jiwa1, Peter Garrard, Atticus H Hainsworth

  • 1Clinical Neuroscience, Division of Clinical Sciences, St George's University of London, London, UK.

Insights

Experimental models of vascular cognitive impairment (VCI) show memory deficits and brain lesions similar to human patients. This analysis links animal models to clinical VCI, aiding research into dementia causes.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Experimental Medicine

Background:

  • Vascular cognitive impairment (VCI) is the second leading cause of dementia after Alzheimer's disease.
  • Key causes include cerebral small vessel disease, multi-infarct dementia, and hereditary vasculopathies like CADASIL.
  • Understanding VCI requires correlating experimental findings with clinical manifestations.

Purpose of the Study:

  • To systematically analyze and relate cognitive and neuropathological features of experimental VCI models to human clinical VCI.
  • To provide a comprehensive overview of current animal models used in VCI research.

Main Methods:

  • A systematic analysis of 107 studies involving 16 distinct experimental models of VCI.
  • Data extraction focused on cognitive deficits and observed neuropathological lesions.
  • Models included global ischemia, chronic hypoperfusion, hypertension, embolic stroke, strategic infarcts, and genetic vasculopathies.

Main Results:

  • Most models exhibited deficits in working and reference memory.
  • Commonly observed lesions included microinfarcts, white matter lesions, hippocampal neuronal death, focal infarcts, and micro-hemorrhages.
  • Bilateral carotid artery occlusion in rats was the most frequently used model, inducing chronic hypoperfusion and white matter injury.

Conclusions:

  • Experimental models effectively recapitulate key cognitive and neuropathological aspects of human VCI.
  • These models are valuable tools for investigating the mechanisms underlying VCI and for developing therapeutic strategies.
  • Further refinement of models can enhance their translatability to clinical VCI.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...